Concepedia

Author

Maryam Althobiti

University of Nottingham

Also Known As

M M Althobiti, Maryam Althobiti, Maryam M. Althobiti, Maryam Musleh Althobiti

32

Publications

674

Citations

12

H-Index

25

Concepts

All Affiliations

University of NottinghamShaqra UniversityNottingham City HospitalCornell UniversityNottingham University Hospitals NHS Trust
MA

About

Maryam Althobiti is an author at University of Nottingham specializing in medicine, cancer biology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

109

2

Engineering

2

2

40

3

Biomolecular Engineering

1

1

12

4

Cell Biology

1

1

69

5

Obstetrics

1

1

28

Maryam Althobiti

×

13

Publications

443

Citations

11

H-Index

YearCitations

Heterogeneity of tumour‐infiltrating lymphocytes in breast cancer and its prognostic significance

Maryam Althobiti, Mohammed A. Aleskandarany, Chitra Joseph,

Histopathology

2018

82

Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer

Chitra Joseph, Maariya Arshad, Sasagu Kurozomi,

Breast Cancer Research and Treatment

2018

69

Enhanced glutamine uptake influences composition of immune cell infiltrates in breast cancer

Rokaya El Ansari, Madeleine L. Craze, Maryam Althobiti,

British Journal of Cancer

2019

55

The prognostic significance of ALDH1A1 expression in early invasive breast cancer

Maryam Althobiti, Rokaya El Ansari, Mohammed A. Aleskandarany,

Histopathology

2020

50

The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor

Martuza Sarwar, Azharuddin Sajid Syed Khaja, Mohammed A. Aleskandarany,

Oncogene

2018

49

The ITIM-Containing Receptor: Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) Modulates Immune Response and Confers Poor Prognosis in Invasive Breast Carcinoma

Chitra Joseph, Mansour Alsaleem, Michael S. Toss,

Cancers

2020

29

The Clinical and Biological Significance of Estrogen Receptor-Low Positive Breast Cancer

Shorouk Makhlouf, Maryam Althobiti, Michael S. Toss,

Modern Pathology

2023

28

Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer

Khloud A. Elsharawy, Maryam Althobiti, Omar J. Mohammed,

Breast Cancer Research and Treatment

2020

18

The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes

Maryam Althobiti, Abir A. Muftah, Mohammed A. Aleskandarany,

Breast Cancer Research and Treatment

2020

15

Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer

Maryam Althobiti, Khloud A. Elsharawy, Chitra Joseph,

Breast Cancer Research and Treatment

2021

15

Page 1